You are viewing the translated version of पुन परीक्षण वा विश्लेषणको लागि लागेको खर्च औषधिधनीले व्यहोर्ने.
Rule 17
Expenses incurred for re-examination or analysis to be borne by the drug owner
Under rule 16, the expenses incurred in testing or analyzing any drug shall be borne by the related drug owner.